keyword
MENU ▼
Read by QxMD icon Read
search

voriconazole periostitis

keyword
https://www.readbyqxmd.com/read/28487449/voriconazole-induced-periostitis-deformans-a-mimicker-of-hpoa
#1
Karim Ladak, Laurence Rubin
No abstract text is available yet for this article.
May 9, 2017: Clinical Medicine & Research
https://www.readbyqxmd.com/read/27990445/voriconazole-induced-periostitis-enthesopathy-in-solid-organ-transplant-patients-case-reports
#2
Monica Sircar, Camille Kotton, David Wojciechowski, Kassem Safa, Hannah Gilligan, Eliot Heher, Winfred Williams, Ravi Thadhani, Nina Tolkoff-Rubin
BACKGROUND: Voriconazole is frequently used to treat fungal infections in solid organ transplant patients. Recently, there have been reports suggesting that prolonged voriconazole therapy may lead to periostitis. AIM: Here we present two cases of voriconazole-induced periostitis in solid organ transplant patients. CASE PRESENTATION: Voriconazole was given to two transplant patients-one with a liver transplant and the second with a heart transplant, to treat their fungal infections...
November 2016: Journal of biosciences and medicines
https://www.readbyqxmd.com/read/27935768/hypertrophic-osteoarthropathy-clinical-and-imaging-features
#3
Felix Y Yap, Matthew R Skalski, Dakshesh B Patel, Aaron J Schein, Eric A White, Anderanik Tomasian, Sulabha Masih, George R Matcuk
Hypertrophic osteoarthropathy (HOA) is a medical condition characterized by abnormal proliferation of skin and periosteal tissues involving the extremities and characterized by three clinical features: digital clubbing (also termed Hippocratic fingers), periostosis of tubular bones, and synovial effusions. HOA can be a primary entity, known as pachydermoperiostosis, or can be secondary to extraskeletal conditions, with different prognoses and management implications for each. There is a high association between secondary HOA and malignancy, especially non-small cell lung cancer...
January 2017: Radiographics: a Review Publication of the Radiological Society of North America, Inc
https://www.readbyqxmd.com/read/27581783/adverse-effects-of-voriconazole-over-a-decade-of-use
#4
REVIEW
Miriam T Levine, Pranatharthi H Chandrasekar
Voriconazole use has increased since the drug's introduction in 2002, and new and unique adverse effects are emerging as patients undergo prolonged therapy. Most concerning is the increased risk of cutaneous malignancies, primarily squamous cell carcinoma (SCC); this risk is duration dependent and the associated malignancies tend to be more aggressive and multifocal. Voriconazole is also associated with phototoxicity (which may be a precursor to malignancy), periostitis, hallucinations and encephalopathy, peripheral neuropathy, alopecia, nail changes, hyponatremia, and other adverse effects...
November 2016: Clinical Transplantation
https://www.readbyqxmd.com/read/27403356/voriconazole-induced-periostitis-mimicking-chronic-graft-versus-host-disease-after-allogeneic-stem-cell-transplantation
#5
Karen Sweiss, Annie Oh, Damiano Rondelli, Pritesh Patel
Voriconazole is an established first-line agent for treatment of invasive fungal infections in patients undergoing allogeneic stem cell transplantation (ASCT). It is associated with the uncommon complication of periostitis. We report this complication in a 58-year-old female undergoing HSCT. She was treated with corticosteroids with minimal improvement. The symptoms related to periostitis can mimic chronic graft-versus-host disease in patients undergoing HSCT and clinicians should differentiate this from other diagnoses and promptly discontinue therapy...
2016: Case Reports in Infectious Diseases
https://www.readbyqxmd.com/read/27376754/voriconazole-induced-periostitis-a-new-rheumatic-disorder
#6
REVIEW
Marwan H Adwan
Over the past few years, several reports of periostitis affecting patients treated with voriconazole appeared in the literature. As rheumatologists are likely to be called to see such patients, a review of the reported cases was undertaken. A systematic search of Pubmed and Google scholar for case reports, case series and observational studies was undertaken. Twenty-six articles including 23 case reports/case series (total 40 patients), a prospective study and two retrospective studies of 58 cases were included...
March 2017: Clinical Rheumatology
https://www.readbyqxmd.com/read/26980228/voriconazole-induced-periostitis-beyond-post-transplant-patients
#7
Joshua D Reber, Gavin A McKenzie, Stephen M Broski
Voriconazole-induced periostitis (VIP) is a rare but increasingly encountered entity since Food and Drug Administration (FDA) approval of the second generation antifungal medication in 2002. Literature reports most commonly include transplant recipients on immunosuppressive therapy simultaneously requiring antifungal therapy. Nontransplant patients receiving long-term voriconazole have an equal risk of developing the disease, but may experience a delay in diagnosis due to a lack of familiarity with the process outside of the post-transplant and/or immunosuppressed population...
June 2016: Skeletal Radiology
https://www.readbyqxmd.com/read/26524731/correlation-of-pain-and-fluoride-concentration-in-allogeneic-hematopoietic-stem-cell-transplant-recipients-on-voriconazole
#8
Megan R Barajas, Kristen B McCullough, Julianna A Merten, Ross A Dierkhising, Gabriel T Bartoo, Shahrukh K Hashmi, William J Hogan, Mark R Litzow, Mrinal M Patnaik, John W Wilson, Robert C Wolf, Robert A Wermers
Supportive care guidelines recommend antimold prophylaxis in hematopoietic stem cell transplant (HSCT) recipients deemed to have high risk for invasive fungal infection, leading to long-term use of voriconazole after allogeneic HSCT in patients who remain immunocompromised. Voriconazole has been associated with periostitis, exostoses, and fluoride excess in patients after solid organ transplantation, HSCT, and leukemia therapy. The aims of this study were to describe the frequency and clinical presentation of patients presenting with pain and fluoride excess among allogeneic HSCT patients taking voriconazole, to identify when a plasma fluoride concentration was measured with respect to voriconazole initiation and onset of pain, and to describe the outcomes of patients with fluoride excess in the setting of HSCT...
March 2016: Biology of Blood and Marrow Transplantation
https://www.readbyqxmd.com/read/26346289/voriconazole-induced-periostitis-post-transplant-an-illustrative-review-of-thoracic-computed-tomography-imaging-manifestations
#9
M Rheinboldt, Z Delproposto, R Agarwal
Voriconazole, first commercially approved in 2002 as a second-generation antifungal agent, is commonly used in the immunocompromised setting as both a therapeutic and prophylactic agent. Since 2009, scattered case reports and small case series have detailed a secondary drug-related hyperfluorosis-induced painful periostitis that can occur in the treated patient population. We present a pictorial review of the thoracic imaging manifestations utilizing 3 illustrative cases in the setting of both solid organ and bone marrow transplantation...
December 2015: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://www.readbyqxmd.com/read/26324277/voriconazole-enhances-the-osteogenic-activity-of-human-osteoblasts-in-vitro-through-a-fluoride-independent-mechanism
#10
Kahtonna C Allen, Carlos J Sanchez, Krista L Niece, Joseph C Wenke, Kevin S Akers
Periostitis, which is characterized by bony pain and diffuse periosteal ossification, has been increasingly reported with prolonged clinical use of voriconazole. While resolution of clinical symptoms following discontinuation of therapy suggests a causative role for voriconazole, the biological mechanisms contributing to voriconazole-induced periostitis are unknown. To elucidate potential mechanisms, we exposed human osteoblasts in vitro to voriconazole or fluconazole at 15 or 200 μg/ml (reflecting systemic or local administration, respectively), under nonosteogenic or osteogenic conditions, for 1, 3, or 7 days and evaluated the effects on cell proliferation (reflected by total cellular DNA) and osteogenic differentiation (reflected by alkaline phosphatase activity, calcium accumulation, and expression of genes involved in osteogenic differentiation)...
December 2015: Antimicrobial Agents and Chemotherapy
https://www.readbyqxmd.com/read/26246048/fluffy-periostitis-induced-by-voriconazole
#11
Sunita Paudyal, Stephen Dummer, Prabhakar Battu, Sylvester Taylor, Saroj Sharma, Laura Carbone
No abstract text is available yet for this article.
December 2015: Arthritis & Rheumatology
https://www.readbyqxmd.com/read/26136804/voriconazole-related-periostitis-presenting-on-magnetic-resonance-imaging
#12
Derik L Davis
Painful periostitis is a complication of long-term antifungal therapy with voriconazole. A high clinical suspicion coupled with imaging and laboratory assessment is useful to establish the diagnosis. Prompt discontinuance of voriconazole typically results in the resolution of symptoms and signs. This report describes the presentation of voriconazole-related periostitis on magnetic resonance imaging.
January 2015: Clinical Cases in Mineral and Bone Metabolism
https://www.readbyqxmd.com/read/26032311/voriconazole-induced-periostitis
#13
Tetiana Glushko, Inés Colmegna
No abstract text is available yet for this article.
October 6, 2015: CMAJ: Canadian Medical Association Journal, Journal de L'Association Medicale Canadienne
https://www.readbyqxmd.com/read/25710343/case-215-voriconazole-induced-periostitis
#14
Tina D Tailor, Michael L Richardson
History A 74-year-old woman presented with multifocal bone pain, including pain in multiple ribs, bilateral shoulders, and bilateral hips. The pain began several months before presentation and was quite severe, ultimately necessitating control with narcotics. At examination, strength in both lower extremities was slightly reduced, sensation and reflexes were intact, and range of motion was full, though painful. There were no notable constitutional symptoms of fever or weight loss. Laboratory work-up was remarkable for elevated alkaline phosphatase level (277 U/L [4...
March 2015: Radiology
https://www.readbyqxmd.com/read/25683739/voriconazole-induced-periostitis-after-allogeneic-stem-cell-transplantation
#15
John H Baird, Belinda K Birnbaum, David L Porter, Noelle V Frey
No abstract text is available yet for this article.
June 2015: American Journal of Hematology
https://www.readbyqxmd.com/read/25587196/fluorosis-and-periostitis-deformans-as-complications-of-prolonged-voriconazole-treatment
#16
Babak Rad, Mohamed Saleem, Susan Grant, Christopher Florkowski, Penelope Coates, David Gordon, Wayne Rankin
We describe a case of development of painful periostitis deformans in a 39-year-old woman who was receiving long-term voriconazole treatment for Aspergillus infection as a complication of orthotopic liver transplant. Measurement of fluoride levels strongly supports fluorosis to be the mechanism of the voriconazole-induced periostitis deformans and supports the concept that such measurements might be of use in predicting this complication of long-term voriconazole treatment.
September 2015: Annals of Clinical Biochemistry
https://www.readbyqxmd.com/read/25484509/painful-periostitis-in-the-setting-of-chronic-voriconazole-therapy
#17
Margaret Skaug, Cedric Spak, Umesh Oza
A 72-year-old woman on chronic voriconazole therapy for recurrent histoplasmosis developed a painful forearm mass. Laboratory and imaging findings were consistent with a diffuse periostitis. Her symptoms resolved after discontinuation of voriconazole. To our knowledge, this is the first case of voriconazole-induced periostitis to be reported in a patient with chronic histoplasmosis.
October 2014: Proceedings of the Baylor University Medical Center
https://www.readbyqxmd.com/read/25327935/elevated-fluoride-levels-and-periostitis-in-pediatric-hematopoietic-stem-cell-transplant-recipients-receiving-long-term-voriconazole
#18
Katherine Tarlock, Darren Johnson, Cathy Cornell, Shawn Parnell, Soheil Meshinchi, K Scott Baker, Janet A Englund
Azole therapy is widely utilized in hematopoietic stem cell transplant (HCT) recipients for the treatment of aspergillus. Complications of voriconazole treatment related to its elevated fluoride content have been described in adults, including reports of symptomatic skeletal fluorosis. We review fluoride levels, clinical, and laboratory data in five pediatric HCT recipients on long-term voriconazole therapy, all found to have elevated serum fluoride levels. Two patients had toxic fluoride levels, one infant had symptoms of significant pain with movement and radiographs confirmed skeletal fluorosis...
May 2015: Pediatric Blood & Cancer
https://www.readbyqxmd.com/read/24992954/plasma-fluoride-level-as-a-predictor-of-voriconazole-induced-periostitis-in-patients-with-skeletal-pain
#19
Woo J Moon, Erica L Scheller, Anupam Suneja, Jacob A Livermore, Anurag N Malani, Varsha Moudgal, Lisa E Kerr, Eric Ferguson, David M Vandenberg
BACKGROUND: Voriconazole is a triazole antifungal medication used for prophylaxis or to treat invasive fungal infections. Inflammation of the periosteum resulting in skeletal pain, known as periostitis, is a reported side effect of long-term voriconazole therapy. The trifluorinated molecular structure of voriconazole suggests a possible link between excess fluoride and periostitis, as elevated blood fluoride has been reported among patients with periostitis who received voriconazole. METHODS: Two hundred sixty-four patients from Michigan were impacted by the multistate outbreak of fungal infections as a result of contaminated methylprednisolone injections...
November 1, 2014: Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
https://www.readbyqxmd.com/read/24699891/voriconazole-associated-soft-tissue-ossification-an-undescribed-cause-of-glenohumeral-joint-capsulitis
#20
Meera Raghavan, Alex Hayes
Voriconazole-related periostitis has been increasingly described in the literature over the last several years as a recognizable disease entity, especially in lung transplant patients. This relationship should be considered when approaching immunosuppressed patients presenting with diffuse bone pain and imaging findings of periostitis. We present a case of voriconazole-associated periostitis, capsular and enthesial ossification and glenuhumeral capsulitis in a patient with a hematologic malignancy. To the authors' knowledge, soft tissue ossification associated with voriconazole has not been described in the radiology literature...
September 2014: Skeletal Radiology
keyword
keyword
42199
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"